Avoid common mistakes on your manuscript.
Erratum to: Oncol Ther DOI 10.1007/s40487-016-0016-0
The author of the above mentioned paper have noticed a mistake in Table 1 following publication and wish to make the following correction.
The reference for the lapatinib study should be 36 (Stacchiotti S, Tamborini E, Lo Vullo S, et al. Phase II study on lapatinib in advanced EGFR-positive chordoma. Ann Oncol. 2013;24:1931–6), and the reference for the 9-nitro-camptothecin study should be 43 (Chugh R, Dunn R, Zalupski MM, et al. Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma. J Clin Oncol. 2005;23:3597–604).
The corrected Table 1 can be found below.
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s40487-016-0016-0.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Heery, C.R. Erratum to: Chordoma: The Quest for Better Treatment Options. Oncol Ther 4, 53–55 (2016). https://doi.org/10.1007/s40487-016-0018-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40487-016-0018-y